We perform a mathematical analysis of a model for drug dissolution-diffusion in non erodible nor swellable devices. We deduce a model and obtain a coupled nonlinear system which contains a parabolic equation for the dissolved drug and an ordinary differential equation for the solid drug, which is assumed to be distributed in the whole domain into microspheres which can differ in size. We analyze existence, uniqueness, and regularity properties of the system. Existence is proved using Schauder fixed point theorem. Lack of uniqueness is shown when the initial concentration of dissolved drug is higher than the saturation density in a region, and uniqueness is obtained in the non-saturated case. A square root function appears in the equation for the solid drug, and is responsible for the lack of uniqueness in the oversaturated case. The regularity results are sufficient for the optimal a priori error estimates of a finite element discretization of the system, which is presented and analyzed here. Simulations illustrating some features of the solutions and a good agreement with laboratory experiments are presented. Finally, we obtain error estimates for the finite element method used to compute the simulations.
Introduction
Numerous mathematical approaches have been proposed to give an adequate theoretical background to the modeling of drug release from polymeric devices [SS, SP] . The interest in this kind of systems has increased in the medical and pharmaceutical industry, because controlled drug-release systems allow for predictable release kinetics, small fluctuations of plasma drug level, diminishing the amount of toxic secondary effects, among other advantages [ECDD, BSBK] . A precise application is a progesteronereleasing intravaginal device called CIDR (Controlled Internal Drug Release, InterAg Manufacturing, New Zealand) depicted in Figure 1 . This is an intravaginal progesterone insert used in the beef cattle, dairy cattle, goat and sheep industries, to release the progesterone at a controlled rate into the bloodstream. In all species, CIDRs are used for the synchronization of estrus, which can be highly beneficial in large herds because groups of cows and heifers can be bred at the same time in a narrow window, achieving a higher pregnancy rate and precise calving dates [LBW, RBO] .
We focus here on a model based on a diffusion equation including a continuous dissolution source described by the Noyes-Whitney equation; other models are based on a moving dissolution front separating a region of coexisting solid and dissolved drug from a region of completely dissolved drug; see [CLG, HILCG] for a detailed description of other models.
Up to now, all mathematical studies have consisted in finding exact solutions for simple geometries using Fourier analysis, or simplified quasi-stationary assumptions, such as fast or slow dissolution rates relative to the diffusion of the already dissolved drug; which are not realistic in many situations (see [CG] and references therein). The goal of this article is to study qualitative as well as quantitative properties of a dissolution-diffusion problem modeling the kinetics of a drug inside a polymeric device, avoiding the assumption of fast or slow dissolution rate relative to the diffusion. We want to avoid this kind of assumption to have a model with a wider range of applicability, since there is a large variety of polymers and drugs, which are combined to design drug-releasing devices [BSBK] .
We first prove existence of solutions, and study uniqueness and regularity properties. Secondly, we propose and analyze an algorithm for the numerical approximation of the solutions, where the regularity estimates are instrumental for obtaining optimal a priori error estimates. The numerical approximations allow us to visualize the behavior of the solutions and compute some measurable quantities with a striking agreement to laboratory experiments performed on CIDR devices. The rest of the article is organized as follows. In Section 2 we deduce the mathematical model and prove existence of solutions in Section 3. Uniqueness of solutions is discussed in Section 4 where uniqueness is proved under the assumption that the initial concentration of dissolved drug is less than or equal to the maximum solubility, and the existence of multiple solutions is proved in a situation where the initial concentration of dissolved drug is above saturation. In Section 5 regularity estimates are obtained for both state variables, concentration of dissolved drug C and area of solid particles per unit volume a. In Section 6 we propose a finite element discretization and show some numerical results, which illustrate on the regularity of the solutions and the good agreement with laboratory experiments. Finally, in Section 7 we prove optimal a priori estimates for the proposed time-space discretization. We end this article with a concluding section summarizing our contributions and discussing potential future work.
Mathematical Model and Weak formulation
We start this section by briefly deducing a model for drug dissolution-diffusion in a non-erodible polymeric device. We consider a model for one drug, which can be either in a solid or in a dissolved state. We assume that the solid drug is distributed in particles of equal density, dispersed throughout the whole device, which can differ in mass and volume, but keep a spherical shape when dissolved [CLG] . We also assume that these non-dissolved particles are so small that they do not affect the diffusion of the dissolved drug, which thus evolves by diffusion with constant coefficient.
Under these assumptions we can state the mathematical model on a domain Ω ⊂ R 3 , occupied by the polymeric device. If C denotes the concentration of dissolved drug, following the same steps used to obtain the diffusion equation with Fick's law we arrive at the following equation:
where D is the drug diffusion coefficient and m is the mass of solid drug per unit volume, so that − ∂m ∂t is the mass of solid drug being dissolved per unit volume per unit time.
Following [CLG] , we use the Noyes-Whitney model for the dissolution of the microspheres, i.e., we assume that the microspheres dissolve at a rate proportional to the product of their surface area and the difference between the saturation solubility C s and the concentration around them. If a denotes the area of the microspheres of solid drug per unit volume, this can be stated mathematically as
where k D is the dissolution rate constant of the solid drug particles. Using relations between radius, area and mass of a sphere we can rewrite (2.2) as 3) where N represents the number of particles per unit volume and ρ s is the intrinsic density of the solid drug particles.
Statement of the problem.. Adding initial conditions and boundary conditions of Neumann and Robin type we arrive at the following problem:
which is an open, bounded and connected set with Lipschitz boundary Γ = Γ N ∪ Γ B . Γ B is the nontrivial part of the boundary where drug is released to the surrounding medium, and Γ N = Γ\Γ B is the insulated part; C B denotes the drug concentration in the bulk medium, k B the external mass transfer coefficient, ∂C ∂n = ∇C · n and n denotes the exterior unit normal to ∂Ω. We assume also that
Proceeding as usual, integrating by parts in Ω, we arrive at the following weak formulation of the problem.
where f, v stands for the evaluation of the functional f ∈ H −1 (Ω) in v ∈ H 1 (Ω) and 
The space H 1 (0, t F ; X) denotes the space of functions in L 2 (0, t F ; X) with weak derivative of first order in L 2 (0, t F ; X); see [T, Chapter 3] for details and main results.
Since we only consider weak solutions to (2.4), we will usually omit the word weak in the sequel.
Remark 2. The following Friedrich inequality holds for a constant C F depending on Γ B and Ω:
As an immediate consequence of this and the trace theorem, the bilinear form B is coercive and bounded, i.e., there exist positive constants C 1 , C 2 such that, for all v, w ∈ H 1 (Ω),
These constants C 1 , C 2 depend only on D, k B , Γ B and Ω.
Existence of solutions
In this section we prove the existence of solutions of (2.4) by using Schauder fixed point theorem. Problems with similar features have been studied in [AV, DS] . The proofs in [AV] are based on a regularization of the non-Lipschitz term and the proofs from [DS] are based on an iteration at the infinite-dimensional level. Even though the proofs of [AV, DS] could be adapted to our problem, we decided to include a new proof to make the article more self-contained. The main result of this section is stated at the end as Theorem 6.
Fixed point formulation.
We notice that if C were known, an explicit formula for a could be obtained by solving an ordinary differential equation. More precisely, the following lemma holds, whose proof is trivial and is thus omitted.
then (C, a) is a weak solution of (2.4). In other words, if C is the weak solution of the (linear) diffusion problem
with a satisfying (3.2), then (C, a) is a weak solution of (2.4).
In the following, we will prove the existence of C satisfying (3.1) resorting to Schauder fixed point theorem [GT, Corollary 11.2, p. 280] . We define
, C s and notice that G is a closed convex subset of B. Furthermore, we define the mapping T : G → B as follows: givenC ∈ G, we define a as
Finally, let C = T (C) be the weak solution of the linear diffusion equation (3.3) with a given by (3.4), which exists and is unique due to the basic theory for parabolic PDE [E] . Moreover, using standard arguments (as in [E, Section 7.1 .2]) we obtain that
In the next section we will prove the existence of the fixed point C of T and existence of weak solutions of (2.4) will follow from the next lemma, whose proof is also trivial and thus omitted.
Lemma 4. If C ∈ G is a fixed point of T , i.e., T (C) = C, and a is given by (3.2), then (C, a) is a weak solution of (2.4).
Existence of a fixed point
We have already noted that G is convex and closed in B, which is one assumption of Schauder fixed point theorem [GT, Corollary 11.2] . Recalling that forC ∈ G, always C :
, the next proposition implies that T (G) ⊂ G, which is another assumption of the theorem.
Ω) with C 0 ≥ 0, and let C be the weak solution of (3.3).
Proof. Setting v = C −C 0 + := max{C −C 0 , 0} in (3.1) and taking into account that we have defined the constantC 0 asC 0 = max C 0 L ∞ (Ω) , C s , we obtain the following equality:
Since C B ≤ C s ≤C 0 , at those points where C −C 0 + = 0 we have C −C 0 > 0 and then
We thereupon conclude that
≤ 0, and thus, for all t > 0,
which readily impliesC 0 − C ≥ 0 for almost every x ∈ Ω and t > 0.
In an analogous way, one can prove that
Another assumption of Schauder fixed point theorem [GT, Corollary 11.2 ] is the continuity of T : G → B. GivenC 1 ,C 2 ∈ B, let a 1 , a 2 be defined by (3.4) withC 1 ,C 2 , instead ofC, respectively, and let C 1 = T (C 1 ), C 2 = T (C 2 ). Then the difference δC := C 1 − C 2 is the weak solution to the diffusion problem
Standard energy estimates for parabolic problems yield
with C 4 depending on the problem parameters. We finally observe that, since the mapping x → (x) + := max{0, x} is Lipschitz continuous with constant one, we have
, so that there exists C 5 depending on the problem parameters such that
We thus conclude that the mapping T : G → B is continuous.
In order to show that all assumptions of Schauder fixed point theorem hold, we still need to prove that
. This is a consequence of the estimate (3.6) and Theorem 2.1 of page 271 in [T] which implies that the space {v ∈ L 2 (0,
. Schauder fixed point theorem [GT, Corollary 11.2] thus implies the existence of a fixed point C ∈ G of T . We summarize the findings of this section in the following theorem.
Then there exists a weak solution of (2.4), i.e., there exists a pair (C, a) of functions
satisfying Definition 1. Furthermore, the following estimates are valid:
and, moreover, if
Uniqueness
In this section we will study the uniqueness of weak solutions of problem (2.4). We will consider two situations that only differ in an assumption on C 0 related to the concentration of maximum solubility C s (or saturation). We first show a situation with C 0 > C s in some region of Ω where there could exist at least two solutions. Then we will show that if C 0 ≤ C s in Ω uniqueness holds.
Initial concentration above saturation
In this section we show that if C 0 > C s in some region of the domain Ω 0 of positive measure and a 0 ≡ 0 in Ω, then there exist at least two solutions of problem (2.4).
On the one hand, Theorem 6 guarantees the existence of a solution (C 1 , a 1 ) of (2.4) such that
Therefore, there exists t 1 > 0 such that
and thus
On the other hand, we define a 2 ≡ 0 and let C 2 be the weak solution of the following classical initial/boundary problem obtained taking a ≡ 0 in (2.4):
(4.1) Then (C 2 , a 2 ) is also a solution of (2.4), which is clearly different from (C 1 , a 1 ), because a 2 ≡ 0 and
Remark 7. In order to have more than one solution, it is necessary that C 0 > C s in some region of the domain. In the next subsection we consider the case C 0 ≤ C s , and we show uniqueness of solution, regardless of the initial condition for a; with the only assumption a 0 ≥ 0. If C 0 ≤ C s and a 0 ≡ 0, the problem (2.4) has a unique solution and it is the pair conformed by a ≡ 0 and C the unique solution of (4.1).
We conjecture that there could be multiple solutions when C 0 > C s in a subset of positive Lebesgue measure even if a 0 > 0 almost everywhere in Ω. We believe that the following situation is feasible: If a 0 is small where C 0 < C s , then a will decrease and could attain zero value in finite time in that region. At the same time, by diffusion, the concentration C could grow up in that region. Then, it could happen that at a certain time t > 0 there will be a region of positive measure contained in Ω, where a(·, t) = 0 and C(·, t) > C s . From this point on there could be two solutions like the ones presented above.
This appearance of multiple solutions is related to the high instability present in the initial phase of crystal formation.
Initial concentration below saturation
Theorem 8 (Uniqueness). If C 0 ≤ C s problem (2.4) has a unique solution.
Proof. Let (C 1 , a 1 ) and (C 2 , a 2 ) be solutions of (2.4). Then
for all w ∈ L 2 (Ω) and almost all t ∈ [0, t F ]. Taking w = a 1 − a 2 we obtain:
e., and C s − C 2 ≥ 0. Also, as a consequence of the second equation in (2.7), 0 ≤ a 1 ≤ a 0 L ∞ (Ω) . Due to the monotonicity of the square root, ( √ a 2 − √ a 1 )(a 1 − a 2 ) ≤ 0, and the second term of (4.2) is less than or equal to zero. Hence
Analogously,
Taking v = C 1 − C 2 and applying [T, Lemma 1.2, Chapter 3, p. 260] we obtain:
and the claim follows by Gronwall inequality.
Regularity
In this section we present regularity results for the solution (C, a) of problem (2.4) under the hypotheses that guarantee unique solution. From now on we assume that the assumptions of Theorems 6 and 8 hold and (C, a) denotes the unique weak solution of (2.4), i.e., 0
and (3.2) holds. In each of the statements that follow, we only mention the additional assumptions that imply further regularity.
Proposition 9. The time derivative of √ a exists and satisfies
Proof. From (3.2) we have that
in the weak sense in Ω × (0, t F ), which in turn implies that
In the next proposition we prove that the spatial regularity of a and √ a is higher if √ a 0 and β are also more regular. It is worth mentioning though, that since there are no space derivatives in the equation for a, there is no regularizing effect. On the other hand, the appearance of √ a on the right-hand side of the equation for a t is responsible of two issues. The value of a reaches zero at finite time, and the space regularity of √ a (resp. a) cannot be higher than H 1 (Ω) (resp. H 2 (Ω)) after that time instant.
Proof. From the assumption on β and the fact that C ∈ L 2 (0,
and
In order to prove higher regularity of C we observe that if the pair (C, a) is a weak solution of (2.4), then C is a weak solution of the diffusion equation
(5.1)
, so that the same proof of Theorem 5 in [E, p. 360] allows us to conclude the following theorem.
Assuming more regularity of C 0 and compatibility with the boundary conditions we obtain higher regularity of the concentration variable C. The proof of this result is analogous to that of Theorem 5 (ii) in [E, p. 361] , taking into account the different boundary conditions, and using that
If we assume further regularity of ∂Ω and that Γ N and Γ B are separated we can prove more space regularity for C.
Remark 14. The assumption dist{Γ N , Γ B } > 0 is only necessary for the existence of θ ∈ C ∞ (R d ) such that θ | Γ N = 0 and θ | Γ B = 1. This will allow for an extension of the boundary values which will in turn permit the use of elliptic regularity to conclude the assertion of the theorem. Many commercial devices have their outer boundary releasing drug to the bulk medium, whereas they have an inner boundary touching a solid elastic core, which is insulating; this assumption is thus fulfilled in practical applications.
Proof. By Theorem 11 we know that C ∈ L ∞ (0, t F ;
(Ω)) and
, for which C(t) is a weak solution of the following (elliptic) problem:
and g| Γ N = 0, and then C(t) is weak solution of
Finally by Corollary 2.2.2.6 [Gr, p. 92], we have that C ∈ H 2 (Ω) and
whereC depend on Ω and D. By Theorems 12 and 11, we have C L ∞ (0,t F ;H 2 (Ω)) is finite.
It is interesting to note that regularity results for this problem have a limitation due to the presence of √ a. This term implies that a vanishes in positive measure sets at finite time, and a(t) does not belong to H 3 (Ω) even if a 0 belongs to H ∞ (Ω).
Discretization and simulations
In this section we present a finite element discretization and some simulations which show an excellent agreement with laboratory experiments. Besides, they allow us to visualize some features of the evolution, such as the lack of regularizing effect on the variable a. The proof of the error estimates is postponed to Section 7.
Finite element discretization and error estimates
We consider a conforming and shape regular triangulation T = T h of Ω, such that ∪ T ∈T h T =Ω with h := max T ∈T h diam (T ) , and the following finite element spaces:
where P is the space of polinomials of degree less than or equal to .
Let ∆t be the time step, and let t n = n∆t, n = 0, 1, . . . . Using a backward Euler discretization for C and taking into account formula (3.2) for a we arrive at the following definition of C n and a n , which denote the approximations of C(t n ) and a(t n ), respectively. Let C n ∈ V h and a n ∈ W h be defined as:
for n = 1, 2, . . . , withC n the L 2 (Ω)-projection of C n on W h ; C 0 ∈ V h and a 0 ∈ W h the initial discrete conditions and (·, ·) denotes the L 2 (Ω) product. We chose C 0 as the Lagrange interpolant of C 0 and a 0 as the L 2 (Ω)-projection of a 0 on W h . Existence of {(C n , a n )} n≥1 , stability bounds and the following error estimates are proven in Section 7. From now on (C, a) denotes the weak solution to (2.4) and {(C n , a n )} n≥1 are given by (6.1).
and C tt L 2 (0,t F ;H −1 (Ω)) and the parameters of the problem, but is independent of the discretization parameters h and ∆t.
Using the regularity estimates from Section 5 we obtain the following corollary.
then the assertion of Theorem (15) holds with C * t F depending on the end time t F , on a 0 L ∞ (Ω) , C 0 H 2 (Ω) and on the parameters k D , C s , β L ∞ (Ω) of the problem, listed in (2.5), but independent of h and ∆t.
Furthermore, if we assume that the assumptions of Theorem 13 hold, then C ∈ L ∞ (0, t F ; H 2 (Ω)) and we find a bound for the error of C in a norm analogous to the L 2 (0, t F ; H 1 (Ω))-norm.
Theorem 17. Assume that Ω has boundary of class C 1,1 and dist{Γ N ,
Then there exists a constantC * t F that depends on the final time t F , on a 0 L ∞ (Ω) , C 0 H 2 (Ω) and on the parameters k D , C s , β L ∞ (Ω) of the problem, listed in (2.5), but is independent of h and ∆t, and
Simulations
We now report some qualitative and quantitative properties of the solutions of (2.4), which we obtained from computing with the numerical method presented in the previous section. The code was developed in MATLAB using ideas from [FPW, RV] for the fast assembling of the linear systems.
We focus on the solution of the problem on the commercial device called CIDR (InterAg Manufacturing, New Zealand) and alluded to in the Introduction (see Figure 1) . We recall that it is initially loaded with 1.9g of Progesterone, and is used by cattle producers to achieve estrous synchronization, which in turn allow a better outcome of artificial insemination; see [DMNG] and references therein.
The parameter values used for the simulation of the drug release from this device, taken from [DMNG] , are stated in Table 1 ; C 0 denotes the initial concentration of dissolved drug and m 0,p , a 0,p stand for the initial mass and area of each particle of solid drug, respectively, whereas Num is the total number of particles in the device, which we assumed evenly distributed. The diffusion coefficients D ap40 and D ap60 correspond to a liberation media with 40% and 60% ethanol in water, respectively, and k D is the dissolution rate of the particles of solid drug. The coefficient k B is a mass transference coefficient and C s is the saturation concentration or maximum solubility. V denotes the volume of the device, ρ s the intrinsic density of the solid drug particles and C B the concentration of drug in the liberation medium. Even though the device is three-dimensional, we assumed that it is composed of two cylindrical pieces, insulated at both ends. One piece is 19cm long with cross section A-A' as in Figure 1 (right) , and another one is 10.37cm long with cross section B-B'. The lengths have been chosen to match the volume of the original device. This simplification allows us to compute on two-dimensional domains, saving a lot of computational time; the comparison of drug release with laboratory experiments is excellent, so this dimension reduction is worthwhile.
Transversal section A-A'
In order to compute on the cylindrical piece with transversal section A-A', we generated a mesh with Gmsh version 2.5.1 [GR] In Figure 3 we show the distribution, at different time instants, of dissolved drug C and area per unit volume of the solid drug particles a.
We can observe that C is smoother than a, due to the regularizing effect of the term D∆C in the differential equation. It can also be observed that there is a front separating the region where a = 0 from the region where a > 0. The function C is smoother and satisfies a diffusion equation in the region where a vanishes, with a Robin-type boundary condition in the outer boundary of the device and Dirichlet-type boundary condition C = C s at the interface where a starts to be positive. In order to observe better this features we plot a 3D-graphic of C and a in Figure 4 for t = 84hs and t = 168hs. We see that C ≈ C s where a > 0 and C looks like a solution to a pure diffusion equation where a = 0. It is also worth observing the lack of regularity of a, in contrast to the regularity of C, which is enforced by the diffusion term D∆C.
We end this section showing in Figure 5 the concentration of dissolved drug C and the area of the solid drug particles for times t greater than seven days. Even though these devices are used for a oneweek period, it is important to know how much drug remains inside the device, and where, in order to optimize their shape to minimize negative consequences to the environment.
Transversal section B-B' Computation of the solution
To compute on the cylindrical piece with transversal section B-B' as in Figure 1 (right), we generated a mesh of the B-B' section with Gmsh, obtaining a triangulation with h = 1.32 × 10 −7 m, 16 184 vertices and 30 888 elements (see Figure 6) .
In Figure 7 we show the distribution of dissolved drug and area per unit volume of the solid drug particles, for different time instants.
Comparison with experimental data
We now compare our numerical results with experimental data obtained at Instituto de Desarrollo Tecnológico para la Industria Química (INTEC-CONICET-UNL). They performed measurements of released drug from CIDR devices in vitro. Several devices were sunk into different stirred containers with 40% and 60% of ethanol in water. The released drug from the devices was measured after 1, 2, 3, 4, 5, 6, 12, 24 hours, and from that moment on, once every 24 hours, for seven days.
We computed the total amount of released drug at time t from each piece using the following formula:
where L is the length of the piece and Ω is the two-dimensional cross section. The sum of the drug released by both pieces according to our numerical calculations, versus the experimental measurements can be observed in Figure 8 . Figure 8 : Drug release according to the numerical simulation versus experimental measurements in a solution of 40% ethanol in water (left) and 60% (right). The simulation was done considering a device composed of two cylindrical pieces. One shaped as the A-A' cut and length 19cm, the other one shaped as B-B' and length 10.37cm. The agreement between our computations and the measurements is remarkable, and comparable to the computations on the three-dimensional domain reported in [DMNG] ; where meshes with almost four million elements were needed.
We observe that the computations according to this proposal fit the experimental data very well. Visually, the fit is equal to the one obtained in [DMNG] , where three-dimensional computations, on a mesh with 3 816 762 elements were performed. It is interesting to note that adding the contributions of the two bi-dimensional meshes that we used, we arrive at 75 280 elements and 39 031 vertices. The computational cost of our proposal is significantly lower.
Remark 18. If we consider initial conditions a 0 ≡ 0 in Ω with C 0 > C s in some region, we know that there are multiple solutions (see Section 4.1). From (6.1) we notice that the numerical method will choose the solution with a ≡ 0, and therefore will approximate the pure diffusion problem (4.1) for the variable C measuring the concentration of dissolved drug.
Proofs of error estimates
The main goal of this section is to prove Theorems 15 and 17, which state error estimates for the discretization proposed in Section 6.
Existence
Observing (6.1) we notice that the definition of C n involves a n−1 and not a n , so that C n can be computed first. Writing the first equation of (6.1) using a basis for V h we are led to a linear system with a symmetric positive definite matrix, and existence of C n is thus guaranteed. The definition of a n in the second equation of (6.1) can be simplified as
where we have changed the integral in the definition of a n by a multiplication by ∆t. In order not to clutter the notation, in the rest of the article we will use · to denote the L 2 (Ω)-norm,
Stability
From the definition of a n we observe that 0 ≤ a n ≤ a n−1 , so that a n ≤ a n−1 ≤ · · · ≤ a 0 . To study the stability of C n , we take v = C n in (6.1) and obtain
By Cauchy inequality and (2.9)
which yields the existence of C 6 , C 7 , C 8 depending on problem data such that
Adding on n from 1 to M := t F /∆t we obtain the following stability estimates:
Error estimation
In what follows we will make use of the L 2 -projection on W h and the Ritz projection on V h . As in the definition of a n ,ū denotes the L 2 -projection of u onto W h , i.e.,ū ∈ W h and (ū,
where C * is a constant that depends only on the dimension of the space. Also, we define R h u as the Ritz projection with respect to the inner product induced by the bilinear form B [·, ·] in H 1 (Ω), i.e.,
Standard interpolation theory [B, BS, Ci] and error estimates of finite elements for stationary problems allow us to affirm that, if Ω has boundary of class C 1,1 and dist(Γ N , Γ B ) > 0, then
withC depending on the mesh regularity.
Remark 19. The assumptions about the regularity of ∂Ω and the distance between boundaries of different kind guarantee that the elliptic problem has H 2 regularity, i.e., given a source term L 2 (Ω) the solution belongs to H 2 (Ω). Estimate (7.4) is a consequence of Cèa Lemma and standard interpolation estimates. The proof of (7.3) uses the Aubin-Nitsche trick.
The following estimates will be used in the proof of the main result. Their proof is straightforwad and will thus be omitted.
In order to prove Theorem 15 we split the error C n − C(t n ) as a sum of two terms:
The term ρ n C is easy to bound using the spatial regularity of C and (7.3)-(7.4). The main goal of the next lemma is to bound the L 2 -norm of θ n C . Lemma 21. Under the assumptions of Theorem 15, we have, for n = 1, 2, . . . , M ,
Proof. If we denote ∂ t C n = (C n − C n−1 )/∆t, the first line of (6.1) reads:
On the other hand, R h C(t n ) satisfies
for all v ∈ V h . Subtracting the above identities, we have,
Recalling that θ n C = C n − R h C(t n ) and setting v = θ n C ∈ V h we are led to the following bound
where we have used that 0 ≤ C ≤ C s (cf. Theorem 6). Owing to Cauchy inequality, we obtain
Thus, using that 0 ≤ a n−1 , a(t n−1 ) ≤ A 0 ,
Finally, taking into account the estimates of Lemma 20
The claim follows by dropping the term ∆tB[θ n C , θ n C ] from the left-hand side.
Lemma 22. Under the assumptions of Theorem 15, we have, for n = 1, 2, . . . , M ,
where C 10 is a constant depending on C s , β and C * .
Proof. Recall that
Subtracting both equations and using that the mapping x → (x) + is Lipschitz, we obtain
where we have used the decomposition (7.5). Then, (7.2) yields
and using (7.3) we readily obtain the claim.
Putting together the previous two lemmas we can prove Theorem 15.
Proof of Theorem 15. Using (α + β) 2 ≤ (1 + ∆t)α 2 + 1 + 1 ∆t β 2 in (7.8) we obtain
And using estimate (7.6) in the above inequality, we have
Adding this inequality to the estimate (7.6), and defining C 11 = max{C 9 + 1, C 2 10 C 9 , C 2 10 + C 9 }, it results
. By induction on n and using 1 + C 12 ∆t ≥ 1 we obtain
Therefore, using the stability bound (7.1), and the fact that (1 + C 12 ∆t) n ≤ e C12tn ≤ e C12t F =: C t F , the claim follows.
Proof of Theorem 17. From (7.7), 
Taking into account the coercivity of the bilinear form, stated in Remark 2,
and using the estimate of the Theorem 15 and Lemma 20, we arrive at
which is the desired assertion.
Conclusions
We have presented a thorough investigation of a mathematical model for the dissolution of a drug dispersed throughout a polymeric matrix and the diffusion of the dissolved drug inside it. The model applies to a wide range of polymeric devices, and does not hinge upon an assumption of the dissolution being fast or slow relative to the diffusion of the dissolved drug. We have deduced the model, which is a coupled nonlinear system. It consists of a parabolic equation for the dissolved drug and an ordinary differential equation for the solid drug, that is assumed to be distributed in the whole domain into microspheres which can differ in size. We have analyzed some qualitative properties of the problem such as existence, uniqueness and regularity of solutions. Uniqueness and regularity are proved when the initial concentration of dissolved drug is below saturation. We have also proved that multiple solutions appear when the initial concentration of dissolved drug is above the saturation, and there are no solid particles at time t = 0.
We have proposed and analyzed a fully discrete finite element method for solving this problem, and proved optimal a priori error estimates in L ∞ (L 2 ) and in L 2 (H 1 ) for the concentration of dissolved drug, and in L ∞ (L 2 ) for the area of solid particles per unit volume. These estimates hinge upon the regularity results previously obtained. We present some simulations that illustrate on qualitative as well as quantitative properties of the solutions. We computed the dissolution and diffusion of Progesterone in a CIDR device, and compared with laboratory experiments, observing an excellent agreement when measuring the amount of released drug at different time instants.
From the applications point of view, it is desirable that the release of drug per unit time is as constant as possible, staying below the toxicity level and above the minimum effective dose. The numerical method developed and tested in this article is an essential building block for solving a shape optimization problem to address this goal of paramount importance for designers. Another goal of this shape optimization problem is to have, at the end of the application procedure, a minimal amount of residual drug, in order to minimize production costs and negative consequences for the environment.
The next step regarding the modeling of drug releasing devices involves dealing with erodible and biodegradable polymers, which would release all the drug and would dematerialize at the end of the treatment, without need of removal. This entails leading with a moving or free boundary, which changes as the domain erodes. We expect that this article sets the basis for the analysis and simulation of these more complicated problems.
